Elite Health Systems (EHSI) EBITDA (2016 - 2025)
Elite Health Systems (EHSI) has disclosed EBITDA for 16 consecutive years, with -$1.2 million as the latest value for Q3 2025.
- On a quarterly basis, EBITDA fell 201.03% to -$1.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$1.2 million, a 28.5% decrease, with the full-year FY2024 number at -$466000.0, down 193.08% from a year prior.
- EBITDA was -$1.2 million for Q3 2025 at Elite Health Systems, down from -$445000.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of $833000.0 in Q4 2024 to a low of -$1.2 million in Q3 2025.
- A 5-year average of -$217736.8 and a median of -$268000.0 in 2021 define the central range for EBITDA.
- Peak YoY movement for EBITDA: crashed 280.43% in 2021, then soared 170.76% in 2023.
- Elite Health Systems' EBITDA stood at -$248000.0 in 2021, then crashed by 106.85% to -$513000.0 in 2022, then soared by 170.76% to $363000.0 in 2023, then soared by 129.48% to $833000.0 in 2024, then plummeted by 239.86% to -$1.2 million in 2025.
- Per Business Quant, the three most recent readings for EHSI's EBITDA are -$1.2 million (Q3 2025), -$445000.0 (Q2 2025), and -$427000.0 (Q1 2025).